Tarsier Pharma Ltd.

Overview

Compare with another stock.

• TickerTARX¹
• IndustryPharmaceutical Preparations¹
• HeadquartersL3¹
• Incorporated inIsrael²
• Business address10 Hama'Apilim St., Zichron Yaacov, 3093765²

See how the biggest companies compare on our leaderboards

Calendar

Drug trials and FDA: recently

1. Jun 29, 2023Phase 3 trial completed Phase 3 trial of TRS01 and FDA approved steroid eye drop (masked) in Non-infectious Anterior Uveitis: primary completion Jun 29, 2023, results posted May 20, 2026 (ClinicalTrials.gov NCT05042609).³

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Filings

10 filings to the SEC since October 2021: 10 other. The latest 10:

1. Jul 16, 2026F-1/A REGISTRATION STATEMENT EDGAR
2. Jul 15, 2026F-1/A REGISTRATION STATEMENT EDGAR
3. Jun 16, 2026F-1/A REGISTRATION STATEMENT EDGAR
4. Jun 8, 2026F-1/A REGISTRATION STATEMENT EDGAR
5. May 18, 2026FWP FREE WRITING PROSPECTUS EDGAR
6. May 18, 2026F-1/A REGISTRATION STATEMENT EDGAR
7. Apr 21, 2026F-1 REGISTRATION STATEMENT EDGAR
8. Mar 31, 2026DRS/A EDGAR
9. Feb 24, 2026DRS/A EDGAR
10. Dec 29, 2025DRS EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Tarsier Pharma Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARTarsier Pharma Ltd.¹
• CIK0002102720
• Incorporated inIsrael¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address10 Hama'Apilim St., Zichron Yaacov, 3093765, Israel¹
• Phone972-4-639-8050¹
• On EDGAR sinceDec 29, 2025¹
• Filings10 in all: F-1/A (5), DRS/A (2), DRS (1), F-1 (1), FWP (1)¹